Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have partnered with the University of Miami College of Engineering for Engineering Cancer Cures, an initiative to develop and deploy innovative technologies for early detection, diagnosis, and treatment of cancer.
Labcorp announced its first U.S. commercial laboratory with an agreement to implement Roche’s cobas Mass Spec solution. This collaboration introduces fully automated mass spectrometry into routine clinical practice—accelerating turnaround times, improving accuracy, and expanding access to advanced diagnostics for patients and providers nationwide.
